The number of deaths after vaccination in Busan rises to 3... Busan City says "Vaccination benefits outweigh risks"

April 29 AZ Vaccine Recipient Female in 50s, April 24 Male in 50s, March Male in 80s

Following the Pfizer vaccine, concerns about supply imbalances are growing for the AstraZeneca vaccine as well. [Image source=Yonhap News]

[Asia Economy Yeongnam Reporting Headquarters Reporter Kim Yong-woo] The number of deaths following vaccination in Busan has increased to three.

Busan City announced on the 3rd that a person in their 50s who received the vaccine died on the 1st.

The woman is reported to have died three days after receiving the AstraZeneca (AZ) vaccine on the 29th of last month.

Prior to this, a person in their 50s who received the AZ vaccine on the 24th of last month also died on the 1st, prompting health authorities to begin an investigation into the vaccine's connection.

The total number of deaths following vaccination in Busan is three.

Health authorities are conducting investigations into the vaccine connection for the deceased, and if causality is recognized, they plan to review compensation for damages.

Busan City stated that an individual in their 80s who died after receiving the AstraZeneca vaccine in March was found to have a cause of death unrelated to the vaccine.

Busan City encouraged vaccination, stating, "Based on government investigation results analyzing adverse reactions and causality with the vaccine so far, the benefits of vaccination outweigh the side effects."

Currently, due to a shortage of supply, Pfizer first-dose vaccinations at district vaccination centers have been completely suspended for three days since the 1st.

Since 1,170 doses of the Pfizer vaccine arrived on the 30th of last month, no additional shipments have been made.

It is known that only about 30,000 doses of the Pfizer vaccine remain at present.

This content was produced with the assistance of AI translation services.